{
  "compound_id": "DB00188",
  "compound_name": "Bortezomib",
  "compound_percentile": 1.0,
  "disease_id": "DOID:9352",
  "disease_name": "type 2 diabetes mellitus",
  "disease_percentile": 0.9726918075422629,
  "metapath_contribution": {
    "CbGaD": 0.09263415240297565,
    "CbGbCtD": 0.19301646968998812,
    "CbGdCrCtD": 0.0018449266686482698,
    "CbGeAlD": 0.023743183527317767,
    "CbGpPWpGaD": 0.05657000174875829,
    "CcSEcCtD": 0.07011081729962634,
    "CrCbGaD": 0.0008765295299048012,
    "CrCrCtD": 0.18509153502472353,
    "CrCtD": 0.37611238410805714
  },
  "n_trials": 0.0,
  "prediction": 0.0421659213309457,
  "status": 0,
  "training_prediction": 0.162955205388784
}